AbbVie Increases US Manufacturing, But Says It’s Not Because Of Tariffs

AbbVie exterior
AbbVie's Skyrizi and Rinvoq continued their steep sales trajectories • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Therapy Areas